ConductScience.org, home

Paper · 17550778

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Badman MK and 5 others. Cell Metab, 2007. Cited by 1,328 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Papers, record 17550778. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17550778

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.
PubMed
Journal
Cell Metab
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
1,328
iCite
Relative citation ratio, by iCite
30.3
iCite
Revised in PubMed
2024-01-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Badman MKMichael K
2Pissios PPavlos
3Kennedy ARAdam R
4Koukos GGeorge
5Flier JSJeffrey S
6Maratos-Flier EEleftheria

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fibroblast Growth FactorsMajor topic
HepatocytesMajor topic
Lipid MetabolismMajor topic
LiverMajor topic
PPAR alphaMajor topic
Adenoviridae
Animals
Cells, Cultured
Fenofibrate
Gene Expression Regulation
Hypolipidemic Agents
Immunoblotting
Ketosis
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Oligonucleotide Array Sequence Analysis
RNA, Messenger
Reverse Transcriptase Polymerase Chain Reaction
Transfection

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 DK056116NIDDK NIH HHSUnited StatesP01DK056116PubMed and NIHNIH RePORTER
R01 DK069983NIDDK NIH HHSUnited StatesR01DK069983PubMed and NIHNIH RePORTER
HL-48739NHLBI NIH HHSUnited StatesR01HL048739PubMed and NIHNIH RePORTER
5P30DK46200-14NIDDK NIH HHSUnited StatesP30DK462001PubMedNIH RePORTER
P30DK046200NIHNIH RePORTER
R01DK056113NIHNIH RePORTER

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01911091Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)BackgroundClinicalTrials.gov
NCT03369145High-fat Overfeeding, Hepatokines and Appetite RegulationBackgroundClinicalTrials.gov

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17,550,773FGF21: a missing link in the biology of fasting.https://conductscience.org/library/papers/17550773

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by840

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,328 citations.

PMIDTitleJournalYearIn PapersSource
42,957,849Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging.Mol Biomed2026https://conductscience.org/library/papers/42957849PubMed
42,948,748Emerging insights into PPARα's role in lean metabolic dysfunction-associated steatotic liver disease: Implications for targeted therapies.Acta Pharm Sin B2026https://conductscience.org/library/papers/42948748PubMed
42,709,008Fenofibrate Protects Against Antipsychotic-Induced Hyperglycemia Through Weight Loss and FGF21 Dependent Mechanisms.FASEB J2026https://conductscience.org/library/papers/42709008PubMed
42,653,122Beneficial Hepatokines in MASLD/MASH: Therapeutic Potentials and Drug Delivery Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42653122PubMed
42,587,786Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease.Cells2026https://conductscience.org/library/papers/42587786PubMed
42,564,630Adipokine in Metabolic Liver Disease: Adipo-Brain-Liver Cross talk.Int J Endocrinol2026https://conductscience.org/library/papers/42564630PubMed
42,512,119Apabetalone Drives a Metabolic Shift Towards Ketogenesis and Reduces Liver Steatosis in Diet-Induced Obesity Mice.Biomedicines2026https://conductscience.org/library/papers/42512119PubMed
42,441,528PPARα Dependent Regulation of Gut Microbiota: Implication for Host Metabolic Homeostasis.Mol Nutr Food Res2026https://conductscience.org/library/papers/42441528PubMed
42,440,064PLX3397 Reshapes Hepatic Lipid Metabolism Independent of Microglial Depletion.Neurosci Bull2026https://conductscience.org/library/papers/42440064PubMed
42,305,630Screening and validation of rabbit monoclonal antibody pair against human FGF21 for human plasma FGF21 high sensitivity bioanalysis.iScience2026https://conductscience.org/library/papers/42305630PubMed

1 to 10 of 840

See all 840 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PPARA5,465PubTator's text mininghttps://conductscience.org/library/genes/5465

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17550778

GET https://conductscience.org/api/papers/v1/17550778/cited_by?page=2